Studien und Publikationen

ECCMID 2015 - P0566/ Comparison of the new Hologic Aptima HIV-1 Quant Dx Assay with the established Abbott RealTime in HIV-1 viral load measurement

EMMD Nordwijk 2015 - The newly developed Cepheid Xpert® HIV-1 VL compared to the established Abbott RealTime HIV-1 viral load measurement

EMMD Nordwijk 2015 - Hologic Aptima HIV-1 Quant Dx Assay Compared to Abbott RealTime in B and non-B Subtypes in daily routine testing

ECCMID 2016 - P0046/ Comparison of the recently launched Hologic Aptima HCV Quant Dx assay with the established Abbott RealTime HCV assay in viral load measurement.

CROI 2016 - 525/ Comparison of Four HCV Viral Load Assays at High Viral Load

ESCV Lissabon 2016 - PP40/ Comparison of the recently launched Hologic Aptima HBV Quant assay with the established Abbott RealTime HBV assay in viral load measurement

eurDrugRes Rom 2016 - O-04/ Next generation sequencing in routine HIV-1 resistance diagnostic - frequency of additional resistance relevant mutations in 2% and 1% population proportions

HIV Glasgow 2016 - P358/ Frequency of additional resistance relevant mutations in 2% and 1% population proportions in next generation sequencing in routine HIV-1 resistance diagnostics

ECCMID 2017 - P1838/ Comparison of the Hologic Aptima HIV-1 Quant Dx Assay with the Abbott RealTime and Roche Cobas 6800 in simultaneously HIV -1 viral load measurement focussing low end detection.

EACS 2017 - PE6/25/ NGS in routine HIV-1 resistance diagnostic-frequency of additional resistance relevant mutationsin 2% and 1% population proportions correlated toviral load and additional patient follow-ups